FindTrial
Sign In

Significance of therapeutic drug monitoring during enteral administration of vancomycin in critically ill patients: a retrospective observational study

Significance of therapeutic drug monitoring during enteral administration of vancomycin in critically ill patients: a retrospective observational study - Therapeutic drug monitoring during enteral vancomycin administration

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000016955
Enrollment
Unknown
Registered
2015-03-30
Start date
2014-04-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clostridium difficile enteritis and methicillin resistant Staphylococcus aureus enteritis

Interventions

None listed

Sponsors

Chiba University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: selected patients who were admitted to the medical surgical ICU (22 beds) of Chiba University Hospital (Chiba, Japan) between December 2006 and January 2014, who were administered oral or enteral VCM, and in whom serum VCM concentrations were measured

Exclusion criteria

Exclusion criteria: Pediatric patients under the age of 18 and patients concomitantly administered parenteral VCM

Design outcomes

Primary

MeasureTime frame
renal dysfunction renal replacement therapy gastrointestinal symptoms (amount of diarrhea or melena)—

Secondary

MeasureTime frame
The length of the ICU stay and ICU mortality—

Countries

Japan

Contacts

Public ContactTakehiko Oami

Chiba University Graduate School of Medicine Department of Emergency and Critical Care Medicine

seveneleven711thanks39@msn.com043-222-7171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026